A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

NCT01511003 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tacrolimus

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]